Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Harte Hanks (HHS) EPS (Weighted Average and Diluted) (2016 - 2025)

Harte Hanks (HHS) has disclosed EPS (Weighted Average and Diluted) for 16 consecutive years, with -$0.05 as the latest value for Q2 2025.

  • On a quarterly basis, EPS (Weighted Average and Diluted) rose 98.7% to -$0.05 in Q2 2025 year-over-year; TTM through Jun 2025 was -$4.47, a 13.45% decrease, with the full-year FY2024 number at -$4.15, down 1876.19% from a year prior.
  • EPS (Weighted Average and Diluted) was -$0.05 for Q2 2025 at Harte Hanks, up from -$0.32 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $3.02 in Q4 2022 to a low of -$3.84 in Q2 2024.
  • A 5-year average of $0.13 and a median of $0.08 in 2023 define the central range for EPS (Weighted Average and Diluted).
  • Peak YoY movement for EPS (Weighted Average and Diluted): skyrocketed 1489.47% in 2022, then crashed 4900.0% in 2024.
  • Harte Hanks' EPS (Weighted Average and Diluted) stood at $0.19 in 2021, then surged by 1489.47% to $3.02 in 2022, then tumbled by 108.61% to -$0.26 in 2023, then fell by 23.08% to -$0.32 in 2024, then surged by 84.38% to -$0.05 in 2025.
  • Per Business Quant, the three most recent readings for HHS's EPS (Weighted Average and Diluted) are -$0.05 (Q2 2025), -$0.32 (Q4 2024), and $0.02 (Q3 2024).